Suppr超能文献

新辅助化疗后即刻假体重建保乳手术治疗浸润性乳腺癌的皮肤相关并发症。

Surgical complications of skin sparing mastectomy and immediate prosthetic reconstruction after neoadjuvant chemotherapy for invasive breast cancer.

机构信息

The Department of Surgical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, NL-1066 CX Amsterdam, The Netherlands.

出版信息

Eur J Surg Oncol. 2012 Jan;38(1):25-30. doi: 10.1016/j.ejso.2011.09.005. Epub 2011 Oct 2.

Abstract

BACKGROUND

Neoadjuvant chemotherapy is gaining acceptance as an option for breast cancer treatment, particularly in young women. These women may seek immediate breast reconstruction after mastectomy even though it is not known whether such preoperative chemotherapy may be detrimental to post-reconstruction wound healing. Therefore, we set out to assess the influence of neoadjuvant chemotherapy for invasive breast cancer on the short-term complications after skin sparing mastectomy and immediate prosthetic reconstruction.

METHODOLOGY

The short-term surgical outcome of 48 immediate breast reconstructions in 37 women treated with neoadjuvant chemotherapy from 2006 through 2009 was prospectively compared to that of 215 immediate reconstructions in 176 women who were operated in the same period without neoadjuvant chemotherapy.

RESULTS

The overall rate of short-term postoperative complications was significantly less among neoadjuvantly treated women (15% vs. 29%; p = 0.042) but this did not result in a reduction of loss of prostheses (8% vs. 11%; p = 0.566).

CONCLUSION

Because neoadjuvant chemotherapy is not associated with an increase in short-term complications after skin sparing mastectomy and immediate prosthetic reconstruction in patients with invasive breast cancer, such combined surgical therapy may be offered as treatment option for this particular group of patients also.

摘要

背景

新辅助化疗作为乳腺癌治疗的一种选择越来越被接受,尤其是在年轻女性中。这些女性可能会在乳房切除术后立即寻求乳房重建,尽管目前尚不清楚术前化疗是否会对重建后的伤口愈合有害。因此,我们着手评估新辅助化疗对保留皮肤的乳房切除术和即刻假体重建后短期并发症的影响。

方法

前瞻性比较 2006 年至 2009 年间接受新辅助化疗的 37 例女性的 48 例即刻乳房重建的短期手术结果与同期无新辅助化疗的 176 例女性的 215 例即刻重建。

结果

新辅助治疗组的短期术后并发症总体发生率明显较低(15%对 29%;p=0.042),但这并未导致假体丢失减少(8%对 11%;p=0.566)。

结论

由于新辅助化疗与保留皮肤的乳房切除术和即刻假体重建后短期并发症的增加无关,因此对于患有浸润性乳腺癌的患者,这种联合手术治疗也可以作为一种治疗选择。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验